Mei Ying Zhu
Technik-/Wissenschafts-/F&E-Leiter bei WUXI XDC CAYMAN INC.
Aktive Positionen von Mei Ying Zhu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
WUXI XDC CAYMAN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 | - |
Karriereverlauf von Mei Ying Zhu
Ehemalige bekannte Positionen von Mei Ying Zhu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REMEGEN CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 | 01.07.2023 |
Bristol-Myers Squibb International Corp. | Corporate Officer/Principal | - | - |
XENCOR, INC. | Private-Equity-Analyst | - | - |
ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
MabPlex USA, Inc.
MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Vorstandsvorsitzender | - | - |
Ausbildung von Mei Ying Zhu
Tsinghua University | Undergraduate Degree |
Illinois Institute of Technology | Graduate Degree |
University of Wisconsin Business School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
China | 3 |
Cayman Islands | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
WUXI XDC CAYMAN INC. | Commercial Services |
REMEGEN CO., LTD. | Health Technology |
ASTELLAS PHARMA INC. | Health Technology |
XENCOR, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
MabPlex USA, Inc.
MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Health Technology |
Bristol-Myers Squibb International Corp. |
- Börse
- Insiders
- Mei Ying Zhu
- Erfahrung